[Sickle cell disease in France in 2008. Achievements and challenges].
Much progress has been made in the past two decades in the diagnosis and management of sickle-cell disease. Clinical, pathophysiological and therapeutic studies have given rise to national procedures for all patients. Life expectancy has improved dramatically in industrialized countries, and the number of sickle-cell patients reaching adulthood is growing. Neonatal diagnosis began in France in 1995 and is crucial for early prevention. Crisis management and long-term surveillance both require dedicated drepanocytosis centers for children and for adults.
Bégué
Pierre
P
L'Académie nationale de médecine.
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications / Q000453:epidemiology* / Q000503:physiopathology; D002648:Child; D005544:Forecasting; D005602:France / Q000453:epidemiology; D006782:Hospitals, Special / Q000458:organization & administration; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000209:etiology; D008017:Life Expectancy; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D012106:Research; D020521:Stroke / Q000209:etiology / Q000517:prevention & control